Back to search

Article

Combination of Arsenic trioxide and Apatinib Synergistically Inhibits Small Cell Lung Cancer by Down-Regulating VEGFR2/mTOR and Akt/c-Myc Signaling Pathway via GRB10

2024-05-10

Abstract excerpt

<title>Abstract</title> <p>Background Small cell lung carcinoma (SCLC) is characterized by poor prognosis. High predilection for -metastasis, -proliferation, and absence of newer therapeutic options. Elucidation of newer pathways characterizing the disease may allow development targeted therapies and favorable outcomes. Methods Combinatorial action of arsenic trioxide (ATO) and apatinib (APA) were tested <itali...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f4d6fd58-79bf-586f-bfce-a2f4e20adbfc
DOI
10.21203/rs.3.rs-4371733/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Combination of Arsenic trioxide and Apatinib Synergistically Inhibits Small Cell Lung Cancer by Down-Regulating VEGFR2/mTOR and Akt/c-Myc Signaling Pathway via GRB10DOI 10.21203/rs.3.rs-4371733/v1
Select a neighboring publication to make it the new centre.